ACTINIUM PHARMACEUTICALS, INC. Cash and Cash Equivalents, Period Increase (Decrease)
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$3.12 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-16.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-03-16
- ACTINIUM PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was -$3.14M, a 162.95% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was $9.09M.
- ACTINIUM PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was -$5.63M.
- ACTINIUM PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was -$3.43M.
- ACTINIUM PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$3.12M.
- ACTINIUM PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$5.12M, a 127.06% decline from fiscal 2015.
- ACTINIUM PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $18.94M, a 1513.76% increase from fiscal 2014.
- ACTINIUM PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2014 was $1.17M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 151 month | Cash and Cash Equivalents, Period Increase (Decrease) 154 month | Cash and Cash Equivalents, Period Increase (Decrease) 157 month | Cash and Cash Equivalents, Period Increase (Decrease) 160 month | Cash and Cash Equivalents, Period Increase (Decrease) 163 month | Cash and Cash Equivalents, Period Increase (Decrease) 166 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | -$3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $5.94M derived: sum of 2 quarters · filed 2018-03-16 | $311.81K derived: sum of 3 quarters · filed 2018-03-16 | -$3.12M 10-K · filed 2018-03-16 | |||||||||
| 2017-09-30 | $9.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $3.45M derived: sum of 2 quarters · filed 2017-11-03 | $22.66K 10-Q · filed 2017-11-03 | $5.01M derived: sum of 4 quarters · filed 2018-03-16 | |||||||||
| 2017-06-30 | -$5.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | -$9.06M 10-Q · filed 2017-08-04 | -$4.07M derived: sum of 3 quarters · filed 2018-03-16 | -$9.00M derived: sum of 4 quarters · filed 2018-03-16 | |||||||||
| 2017-03-31 | -$3.43M 10-Q · filed 2017-05-15 | $1.56M derived: sum of 2 quarters · filed 2018-03-16 | -$3.37M derived: sum of 3 quarters · filed 2018-03-16 | -$5.12M derived: sum of 4 quarters · filed 2018-03-16 | |||||||||
| 2016-12-31 | $4.99M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $64.05K derived: sum of 2 quarters · filed 2018-03-16 | -$1.69M derived: sum of 3 quarters · filed 2018-03-16 | -$5.12M 10-K · filed 2018-03-16 | |||||||||
| 2016-09-30 | -$4.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | -$6.68M derived: sum of 2 quarters · filed 2017-11-03 | -$10.12M 10-Q · filed 2017-11-03 | -$9.23M derived: sum of 4 quarters · filed 2018-03-16 | |||||||||
| 2016-06-30 | -$1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | -$5.19M 10-Q · filed 2017-08-04 | -$4.31M derived: sum of 3 quarters · filed 2018-03-16 | -$5.50M derived: sum of 4 quarters · filed 2018-03-16 | |||||||||
| 2016-03-31 | -$3.44M 10-Q · filed 2017-05-15 | -$2.56M derived: sum of 2 quarters · filed 2018-03-16 | -$3.75M derived: sum of 3 quarters · filed 2018-03-16 | $2.92M derived: sum of 4 quarters · filed 2018-03-16 | |||||||||
| 2015-12-31 | $881.23K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$308.78K derived: sum of 2 quarters · filed 2018-03-16 | $6.36M derived: sum of 3 quarters · filed 2018-03-16 | $18.94M 10-K · filed 2018-03-16 | |||||||||
| 2015-09-30 | -$1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $5.48M derived: sum of 2 quarters · filed 2016-10-28 | $18.06M 10-Q · filed 2016-10-28 | $13.01M derived: sum of 4 quarters · filed 2017-03-16 | |||||||||
| 2015-06-30 | $6.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $19.25M 10-Q · filed 2016-07-29 | $14.20M derived: sum of 3 quarters · filed 2017-03-16 | $11.28M derived: sum of 4 quarters · filed 2017-03-16 | |||||||||
| 2015-03-31 | $12.58M 10-Q · filed 2016-05-10 | $7.53M derived: sum of 2 quarters · filed 2017-03-16 | $4.61M derived: sum of 3 quarters · filed 2017-03-16 | $13.41M derived: sum of 4 quarters · filed 2017-03-16 | |||||||||
| 2014-12-31 | -$5.04M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$7.96M derived: sum of 2 quarters · filed 2017-03-16 | $829.02K derived: sum of 3 quarters · filed 2017-03-16 | $1.17M 10-K · filed 2017-03-16 | |||||||||
| 2014-09-30 | -$2.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $5.87M derived: sum of 2 quarters · filed 2015-10-30 | $6.22M 10-Q · filed 2015-10-30 | $7.76M derived: sum of 4 quarters · filed 2016-03-11 | |||||||||
| 2014-06-30 | $8.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $9.14M 10-Q · filed 2015-08-07 | $10.68M derived: sum of 3 quarters · filed 2016-03-11 | $9.02M derived: sum of 4 quarters · filed 2016-03-11 | |||||||||
| 2014-03-31 | $344.42K 10-Q · filed 2015-05-08 | $1.89M derived: sum of 2 quarters · filed 2016-03-11 | $227.45K derived: sum of 3 quarters · filed 2016-03-11 | $2.64M derived: sum of 4 quarters · filed 2016-03-11 | $5.88M 10-Q · filed 2014-05-12 | ||||||||
| 2013-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | -$116.96K derived: sum of 2 quarters · filed 2016-03-11 | $2.29M derived: sum of 3 quarters · filed 2016-03-11 | -$85.30K 10-K · filed 2016-03-11 | $5.53M 10-K · filed 2014-02-28 | ||||||||
| 2013-09-30 | -$1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $750.18K derived: sum of 2 quarters · filed 2014-10-31 | -$1.63M 10-Q · filed 2014-10-31 | $1.42M derived: sum of 4 quarters · filed 2014-10-31 | $3.99M 10-Q · filed 2013-11-14 | ||||||||
| 2013-06-30 | $2.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $31.66K 10-Q · filed 2014-08-12 | $3.08M derived: sum of 3 quarters · filed 2014-08-12 | $1.15M derived: sum of 4 quarters · filed 2014-08-12 | $5.65M 10-Q · filed 2013-08-13 | ||||||||
| 2013-03-31 | -$2.38M 10-Q · filed 2014-05-12 | $673.22K derived: sum of 2 quarters · filed 2014-05-12 | -$1.26M derived: sum of 3 quarters · filed 2014-05-12 | -$2.17M derived: sum of 4 quarters · filed 2014-05-12 | $3.24M 10-Q · filed 2013-05-15 | ||||||||
| 2012-12-31 | $3.05M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $1.12M derived: sum of 2 quarters · filed 2014-02-28 | $203.79K derived: sum of 3 quarters · filed 2014-02-28 | -$85.13K 10-K · filed 2014-02-28 | $5.62M 10-K · filed 2013-03-29 | ||||||||
| 2012-09-30 | -$1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$2.85M derived: sum of 2 quarters · filed 2013-11-14 | -$3.14M 10-Q · filed 2013-11-14 | -$150.00 10-Q · filed 2012-11-14 | |||||||||
| 2012-06-30 | -$914.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | -$1.20M 10-Q · filed 2013-08-13 | -$8.00 10-Q/A · filed 2012-08-29 | -$1.20M derived: sum of 3 quarters · filed 2013-08-13 | -$1.20M derived: sum of 4 quarters · filed 2013-08-13 | ||||||||
| 2012-03-31 | -$288.92K 10-Q · filed 2013-05-15 | $0.00 10-Q · filed 2012-04-23 | -$288.92K derived: sum of 2 quarters · filed 2013-05-15 | -$288.92K derived: sum of 3 quarters · filed 2013-05-15 | |||||||||
| 2011-12-31 | $0.00 10-Q · filed 2012-04-23 | $0.00 derived: sum of 2 quarters · filed 2012-04-23 | $5.51M 10-K · filed 2013-03-29 | $0.00 10-K · filed 2012-04-12 | |||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | $0.00 10-Q · filed 2012-11-14 | ||||||||||
| 2011-06-30 | $0.00 10-Q/A · filed 2012-08-29 | ||||||||||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-12 | -$34.91K derived: sum of 2 quarters · filed 2012-04-12 | -$1.97K 10-K · filed 2012-04-12 | ||||||||||
| 2010-09-30 | -$34.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$1.97K 10-Q · filed 2011-11-14 | |||||||||||
| 2010-06-30 | $32.94K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |